Market Insights Consumer OTC Pharmaceuticals

Sleep Aids - North America

North America

Revenue in the Sleep Aids market amounts to €2.07k in 2024. The market is expected to grow annually by 3.85% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (€1,950 in 2024).
In relation to total population figures, per person revenues of €4.06 are generated in 2024.

Key regions: Philippines, Indonesia, United Kingdom, Canada, Thailand

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Sleep Aids market in North America is experiencing steady growth and development, driven by changing customer preferences, emerging trends, and local special circumstances.

Customer preferences: Customers in North America are increasingly prioritizing their sleep health and seeking solutions to improve their quality of sleep. This shift is driven by various factors, including rising awareness about the importance of sleep for overall well-being and the growing prevalence of sleep disorders. As a result, there is a growing demand for sleep aids that can help individuals fall asleep faster, stay asleep longer, and wake up feeling refreshed.

Trends in the market: One of the key trends in the Sleep Aids market in North America is the rising popularity of natural and organic sleep aids. Customers are becoming more conscious about the ingredients used in sleep aids and are opting for products that are free from artificial additives and chemicals. This trend is driven by the overall shift towards natural and organic products in the health and wellness industry. Another trend in the market is the increasing adoption of technology-based sleep aids. With the advancement of technology, customers now have access to a wide range of sleep tracking devices, smart mattresses, and mobile applications that can monitor and analyze their sleep patterns. These products provide personalized insights and recommendations to improve sleep quality, making them highly appealing to tech-savvy customers.

Local special circumstances: One of the unique factors shaping the Sleep Aids market in North America is the high prevalence of sleep disorders in the region. According to studies, a significant portion of the population in North America suffers from sleep disorders, such as insomnia and sleep apnea. This high prevalence creates a large customer base for sleep aids, driving the growth of the market. Furthermore, the aging population in North America is also contributing to the growth of the Sleep Aids market. As individuals age, they are more likely to experience sleep disturbances and disorders. This demographic trend is fueling the demand for sleep aids that can alleviate these issues and improve sleep quality among older adults.

Underlying macroeconomic factors: The Sleep Aids market in North America is also influenced by macroeconomic factors, such as rising disposable incomes and increasing healthcare expenditure. As disposable incomes increase, customers have more purchasing power to invest in sleep aids and other products that can enhance their sleep quality. Additionally, the growing healthcare expenditure in the region has led to improved access to healthcare services, including sleep clinics and specialist consultations, which further drives the demand for sleep aids. In conclusion, the Sleep Aids market in North America is experiencing growth and development due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The increasing focus on sleep health, the popularity of natural and organic sleep aids, the adoption of technology-based solutions, the high prevalence of sleep disorders, the aging population, rising disposable incomes, and increasing healthcare expenditure are all contributing to the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.